Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.750
+0.300 (12.24%)
At close: Aug 6, 2025, 4:00 PM
2.970
+0.220 (8.00%)
After-hours: Aug 6, 2025, 5:45 PM EDT
Splunk Market Cap
Sera Prognostics has a market cap or net worth of $103.60 million as of August 6, 2025. Its market cap has decreased by -59.32% in one year.
Market Cap
103.60M
Enterprise Value
-13.80M
1-Year Change
-59.32%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $103.60M, a decrease of -78.78%. That is a compound annual growth rate of -31.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 92.30M | -66.43% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | 488.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.04B |
| Johnson & Johnson | 410.84B |
| AbbVie | 346.78B |
| Novartis AG | 228.98B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 227.88B |
| UnitedHealth Group | 222.96B |
| Novo Nordisk | 200.63B |